Instant NanoBiosensors (INB) is an innovation-driven biotechnology company dedicated to advancing precision diagnostics through cutting-edge proteomics and genomics solutions.
A. Light Sensing Biomarker Analyzer
The Light Sensing Biomarker Analyzer delivers high sensitivity and real-time performance for protein analysis and antibody selection. Powered by proprietary FOPPR technology, it provides label-free detection of low-abundance biomarkers using minimal sample volume while ensuring excellent reproducibility. This unique capability makes it a powerful tool for accelerating biomarker development, antibody analysis, therapeutic development, and translational research—including the early detection of blood-based biomarkers for neurodegenerative diseases such as Alzheimer's.
B. INB-G8 APOE Genotyping Analyzer
The INB-G8 Genotyping Analyzer is an automated system that integrates PCR amplification and capillary electrophoresis (CE) for comprehensive APOE six-type genotyping (ε2/ε3/ε4) in a single run. Capable of processing up to eight samples per run, the analyzer accepts buccal swab, saliva, or blood samples.
C. INVISION INLab NGS Solution
This solution is a fully automated, end-to-end next-generation sequencing (NGS) system designed to optimize precision medicine workflows and accelerate clinical decision-making for cancer treatment. The platform delivers seamless integration across the entire process, ensuring accuracy, reproducibility, and efficiency for laboratories and healthcare providers.
The solution incorporates:
✅ iNA Automated Nucleic Acid Purification Platform – featuring automated FFPE deparaffinization and high-yield cfDNA extraction (up to 8cc) for superior purity.
✅ iNA NGS Library Preparation Workstation – providing reliable, hands-free automation for complex library workflows.
✅ iNA High-Performance NGS Multiplex Panels – tailored for cancer monitoring, mutation detection, and therapy guidance.
✅ iNA One-click CAP-certified Reporting Software – integrated with LIMS to generate standardized, actionable reports.
D.Leukemia INLab NGS Solution
The Leukemia INLab NGS Solution is a next-generation sequencing platform designed for comprehensive leukemia genotyping, MRD tracking, and precision diagnostics. It combines advanced chemistry and automation to deliver rapid, accurate, and cost-efficient genomic insights.
Key Advantages:
✅ DimerOff™ Technology: Significantly reduces primer-dimer formation and sequencing noise, ensuring cleaner data and enhanced mutation detection sensitivity.
✅ Efficiency at Scale: Achieves up to 50% lower sequencing cost with a three-day turnaround time, optimizing laboratory throughput.
✅ MRD & MPN Tracking: Enables precise monitoring of measurable residual disease and myeloproliferative neoplasms, supporting personalized treatment and long-term follow-up.
✅ Custom Clinical Panels: Offers flexible, cost-effective NGS panel development for both clinical practice and translational research applications.
✅ Global Accessibility: Designed for cost-effective implementation across decentralized and international clinical settings, making high-quality genomic testing more accessible.
\uD83D\uDE80 To expand global access to this proven model, Instant NanoBiosensors is actively seeking strategic partners to collaborate on multiple fronts:
\uD83D\uDD27 Why partner with us?
• Annual production capacity exceeding 300,000 reagent kits
• Reagent quality comparable to Qiagen standards
• Streamlined automation requiring only 1–2 operators
• Proprietary DimerOFF™ technology ensuring cleaner sequencing results
• Clinically validated performance in AML, MPN, and solid tumor diagnostics
","pdfs":[],"tol":[],"categories":[{"id":"prod=medica2026.01.02.02.02","label":"Next-generation sequencing (NGS)","catalogIndex":"01.02.02.02","eventIcons":[{"key":"medica2026","small":"https://www.medica.de/vis-content/event-medica2026/all-exh/Event-SzHinHZFRDix2fwVNyP4ag.png","tiny":"https://www.medica.de/vis-content/event-medica2026/all-exh/Event-0mOSbpheSRej6t2ZLcI1AA.png","label":"MEDICA 2026"}],"productList":[{"id":"prodinfo=Vk8eUbreT9WGdEEx72A63A","label":"INB-D8 Light-Sensing Biomarker Analyzer"},{"id":"prodinfo=7ocbz9PwS829hVPGYwEzeA","label":"iNA Automated Nucleic Acid Purification Platform"},{"id":"prodinfo=7oEr4uNyR8Cs1rUdTFu77g","label":"INB-G8 APOE Genotyping Analyzer"},{"id":"prodinfo=ANzCMsxURPC4ZK8fu1QPoA","label":"iNA NGS Library Preparation Workstation"},{"id":"prodinfo=O2JaErg0RlWwTdLoIEYYLw","label":"Leukemia INLab NGS Solution"},{"id":"prodinfo=hDSxqQCZSJuXnELGMLKXPg","label":"INVISION INLab NGS Solution"}],"hierarchy":[{"id":"01","label":"Clinical Diagnostics & Therapeutic Technologies"},{"id":"01.02","label":"Laboratory, IVD & Diagnostics"},{"id":"01.02.02","label":"Molecular diagnostics & genomics"},{"id":"01.02.02.02","label":"Next-generation sequencing (NGS)"}]}],"write":false,"lastModified":"2026-11-03T21:12:01Z","tagsAreEditable":false,"xtagsAreEditable":false,"isGetInTouchAllowed":false}